Showing 1021-1040 of 8875 for: Cochrane Systematic Reviews Back
- Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD)
Cochrane Systematic Reviews, 3-Sep-2021
Autistic spectrum disorder (ASD) is an increasingly recognised neurodevelopmental condition; that is, a neurologically-based condition which interferes with the acquisition, retention or application of specific skills. ASD is characterised by challenges w
- Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents
Cochrane Systematic Reviews, 18-Oct-2006
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 4, 2006.
- Behavioural and cognitive behavioural training interventions for assisting foster carers in the management of difficult behaviour
Cochrane Systematic Reviews, 24-Jan-2007
The provision of training for foster carers is now seen as an important factor contributing to the successful outcome of foster care placements. Since the late 1960s, foster carer training programs have proliferated, and few of the many published and unpu
- Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children
Cochrane Systematic Reviews, 7-Dec-2011
Faecal incontinence is a common and potentially distressing disorder of childhood.
- Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years
Cochrane Systematic Reviews, 16-Jan-2012
Early-onset child conduct problems are common and costly. A large number of studies and some previous reviews have focused on behavioural and cognitive-behavioural group-based parenting interventions, but methodological limitations are commonplace and evi
- Behavioural and cognitive‐behavioural interventions for outwardly directed aggressive behaviour in people with intellectual disabilities
Cochrane Systematic Reviews, 6-Feb-2023
Outwardly directed aggressive behaviour in people with intellectual disabilities is a significant issue that may lead to poor quality of life, social exclusion and inpatient psychiatric admissions. Cognitive and behavioural approaches have been developed
- Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population
Cochrane Systematic Reviews, 31-May-2021
Social networking platforms offer a wide reach for public health interventions allowing communication with broad audiences using tools that are generally free and straightforward to use and may be combined with other components, such as public health poli
- Behavioural interventions for dysmenorrhoea
Cochrane Systematic Reviews, 18-Jul-2007
Dysmenorrhoea refers to the occurrence of painful menstrual cramps of uterine origin and is a common gynaecological condition with considerable morbidity. The behavioural approach assumes that psychological and environmental factors interact with, and inf
- Behavioural interventions for smoking cessation: an overview and network meta‐analysis
Cochrane Systematic Reviews, 4-Jan-2021
Smoking is a leading cause of disease and death worldwide. In people who smoke, quitting smoking can reverse much of the damage. Many people use behavioural interventions to help them quit smoking; these interventions can vary substantially in their conte
- Behavioural interventions to promote workers' use of respiratory protective equipment
Cochrane Systematic Reviews, 7-Dec-2016
Respiratory hazards are common in the workplace. Depending on the hazard and exposure, the health consequences may include: mild to life-threatening illnesses from infectious agents, acute effects ranging from respiratory irritation to chronic lung condit
- Behavioural therapies versus other psychological therapies for depression
Cochrane Systematic Reviews, 16-Oct-2013
Behavioural therapies represent one of several categories of psychological therapies that are currently used in the treatment of depression. However, the effectiveness and acceptability of behavioural therapies for depression compared with other psycholog
- Behavioural treatment for chronic low‐back pain
Cochrane Systematic Reviews, 7-Jul-2010
Behavioural treatment is commonly used in the management of chronic low-back pain (CLBP) to reduce disability through modification of maladaptive pain behaviours and cognitive processes. Three behavioural approaches are generally distinguished: operant, c
- Belatacept for kidney transplant recipients
Cochrane Systematic Reviews, 24-Nov-2014
Most people who receive a kidney transplant die from either cardiovascular disease or cancer before their transplant fails. The most common reason for someone with a kidney transplant to lose the function of their transplanted kidney necessitating return
- Belimumab for systemic lupus erythematosus
Cochrane Systematic Reviews, 25-Feb-2021
Belimumab, the first biologic approved for the treatment of systemic lupus erythematosus (SLE), has been shown to reduce autoantibody levels in people with SLE and help control disease activity.
- Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
Cochrane Systematic Reviews, 13-Aug-2012
Indolent B cell lymphoid malignancies include follicular lymphoma, small lymphocytic lymphoma, mantle cell lymphoma, lymphoplasmacytic lymphoma and marginal zone lymphomas. Chronic lymphocytic leukaemia (CLL) is a lymphoid malignancy similar to small lymp
- Benperidol for schizophrenia
Cochrane Systematic Reviews, 20-Apr-2005
Benperidol is a relatively old antipsychotic drug that has been marketed since 1966. It has been used in Germany for 30 years but is also available in Belgium, Greece, Italy, the Netherlands and the UK. Benperidol is a butyrophenone antipsychotic, with th
- Benzodiazepines and related drugs for insomnia in palliative care
Cochrane Systematic Reviews, 22-Nov-2013
Insomnia, a subjective complaint of poor sleep and associated impairment in daytime function, is a common problem. Currently, benzodiazepines are the most used pharmacological treatment for this complaint. They are considered helpful for occasional short-
- Benzodiazepines for alcohol withdrawal
Cochrane Systematic Reviews, 17-Mar-2010
Alcohol abuse and dependence represents a serious health problem worldwide with social, interpersonal and legal interpolations. Benzodiazepines have been widely used for the treatment of alcohol withdrawal symptoms. Moreover it is unknown whether differen
- Benzodiazepines for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 20-Jan-2018
Tardive dyskinesia (TD) is a disfiguring movement disorder, often of the orofacial region, frequently caused by using antipsychotic drugs. A wide range of strategies have been used to help manage TD, and for those who are unable to have their antipsychoti
- Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
Cochrane Systematic Reviews, 5-Aug-2019
Catatonia is a debilitating disorder of movement and volition associated with schizophrenia and some other mental illnesses. People with catatonia are more likely to require hospitalisation and highly supervised care than those without the disorder. They
